Sp1135
SURGICAL MANAGEMENT OF BILIARY AND INTESTINAL OBSTRUCTION BECAUSE OF PANCREATIC HEAD DISEASE
Date
May 21, 2024
Tracks
Related Products
SURVODUTIDE REDUCES LIVER FAT CONTENT, TRANSAMINASES, AND FIBROSIS MARKERS WITH GOOD SAFETY PROFILE IN PEOPLE WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH): AN INTERIM ANALYSIS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 TRIAL
BACKGROUND: Survodutide is a novel glucagon receptor/glucagon-like peptide-1 receptor dual agonist under investigation for treatment in advanced liver disease associated with metabolic dysfunction-associated steatohepatitis (MASH), the most severe form of metabolic dysfunction-associated steatotic…
Best of Pancreatic Diseases
SOCIETY: SSAT
A COMPARATIVE EVALUATION OF FIBROSIS AMONG PATIENTS WITH RECURRENT ACUTE AND CHRONIC PANCREATITIS UNDERGOING TOTAL PANCREATECTOMY WITH ISLET AUTOTRANSPLANTATION (TPIAT)
Fibrosis is commonly used as the criterion standard for diagnosing chronic pancreatitis (CP). However, there has never been a study comparing fibrosis among patients with recurrent acute pancreatitis (RAP) and CP…
Best of Pancreatic Diseases
SOCIETY: SSAT